5-amino-1-(4-chlorophenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 500mg

2-(4-(Difluoromethoxy)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

3-methyl-1-(4-methylbenzyl)piperazin-2-one, 95.0%, 100mg

Zirconium(IV) oxide, nano, hydrophobic, ROTI®nanoMETIC, 3 nm, hydrophobic, 1 g, glass packaging

3-(TERT-BUTYL)-8-CHLORO-1-IODOIMIDAZO[1,5-A]PYRAZINE, 95.0%, 100mg

(R)-1-(m-Tolyl)ethanamine hydrochloride, 95.0%, 2.5g

1-(4-Amino-2-bromophenyl)pyrrolidin-2-one, 95%, 5g

2-(Aminomethyl)-1-N-Boc-piperidine, 90.0%, 5g

3-bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine, 95.0%, 100mg

(1R)-1-(3-Fluoro-4-methylphenyl)ethan-1-amine hydrochloride, 95.0%, 250mg

3-Methoxy-3-oxo-2-(thiophen-2-ylmethyl)propanoic acid, 95%, 250mg

ROTI®ContiPlate Sab4plus

3',5'-Dimethyl-1'-(2-methyl-allyl)-1H,1'H-[3,4']bipyrazolyl-5-carboxylic acid, 95.0%, 250mg